Investment focus

The current SHS V fund is investing in 12 to 15 companies until 2023.  Our investment managers are willing to build a well-balanced and attractive portfolio.

In the following, the scope of potential SHS investments is described:

Industry

  • Life sciences
  • Medical technology
  • Diagnostics
  • Applied technologies
  • Digital Health
  • Industrial Biotechnology / pharmaceuticals (no drug development)

Geographical focus

  • Germany
  • Austria
  • Switzerland
  • Scandinavia
  • Benelux countries

Reasons for investment

  • Growth capital/Strengthening equity
  • MBO/MBI
  • Change of shareholders/succession
  • M&A financing
  • Spin-off/Carve-out

Company situation

  • Growth/expansion
  • Internationalization
  • Succession/company sale
  • Operating profit may be negative for growth- or technology-related reasons

Transaction and investment values

  • Transaction value: up to € 100m
  • Investment amount SHS V: up to € 30m, with a co-investor from the SHS-network up to € 60m

Investment types

  • Majorities, qualified minorities
  • Equity & financial instruments similar to equity